|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
Drugs - An Easy Target
The tip of the iceberg is clearly visible and getting larger by the day. Drug counterfeiting and diversion are flourishing in today's world of tumbling international trade barriers, easy global marketing reach via the Internet, and simple access to sophisticated manufacturing and packaging technologies. Drug counterfeiting has steadily evolved from small-scale, opportunistic, activities in less regulated parts of the world to what has now become a widespread global threat to consumers and brand owners. Informed estimates put the size of the annual global market in fake drugs somewhere in the region of US$30 billion, representing about seven per cent of pharmaceutical industry revenue. Even more alarming are results of surveys showing that counterfeit drugs in some countries comprise in excess of 50 per cent of the market. These activities clearly put consumers at risk, threaten corporate and brand integrity, and generate significant cash for organised crime and terrorist groups.
Pharmaceuticals are an attractive target to counterfeiters, mainly because they have a high value in relation to their physical bulk. Consider some of the anti-cancer and anti-HIV treatments where a single pallet of product can represent many millions of dollars - for example, a standard 12-week course of Serostim treatment for HIV/AIDS patients costs approximately US$21,000.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
“PACK DIFFERENT” with EMBALLAGE 2008
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
